Zosano Pharma to Present at the H.C. Wainwright Virtual Global Investment Conference
03 9월 2021 - 5:30AM
Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage
biopharmaceutical company, today announced that its president and
chief executive officer, Steven Lo, will present a company overview
at the H.C. Wainwright Global Investment Conference available on
demand beginning September 13, 2021 at 7:00am ET.
A live webcast of the event will be available on the company’s
website at http://ir.zosanopharma.com/events-presentations. The
archived webcast will remain available for 30 days following the
date of the presentation.
About Zosano PharmaZosano Pharma Corporation is
a clinical-stage biopharmaceutical company focused on developing
products where rapid administration of approved molecules with
established safety and efficacy profiles may provide substantial
benefit to patients, in markets where patients remain underserved
by existing therapies. The company’s transdermal microneedle system
technology consists of titanium microneedles coated with drug that
are designed to enable rapid systemic administration of
therapeutics to patients. Zosano’s lead product candidate is M207,
which is a proprietary formulation of zolmitriptan designed to be
delivered via its transdermal microneedle system technology, as an
acute treatment for migraine. Learn more at
www.zosanopharma.com.
Zosano Contacts:Christine MatthewsChief
Financial Officer 510-745-1200
Zosano PR:Sylvia Wheeler or Alexandra
Santosswheeler@wheelhouselsa.com or asantos@wheelhouselsa.com
Zosano Pharma (NASDAQ:ZSAN)
과거 데이터 주식 차트
부터 7월(7) 2024 으로 8월(8) 2024
Zosano Pharma (NASDAQ:ZSAN)
과거 데이터 주식 차트
부터 8월(8) 2023 으로 8월(8) 2024
Zosano Pharma Corporation (나스닥)의 실시간 뉴스: 최근 기사 0
More News Articles